Anthera Pharmaceuticals, Inc. Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ANTH and buy or sell other stocks, ETFs, and their options commission-free!About ANTH
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life-threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy.
CEOJohn Craig Thompson, MBA
CEOJohn Craig Thompson, MBA
Employees21
Employees21
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2004
Founded2004
Employees21
Employees21
ANTH Key Statistics
Market cap0.00
Market cap0.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume12.94K
Average volume12.94K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume3.50K
Volume3.50K
52 Week high$0.001
52 Week high$0.001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
Anthera Pharmaceuticals, Inc. Common Stock(ANTH) stock is priced at $0.00, giving the company a market capitalization of 0.
On 2026-05-14, Anthera Pharmaceuticals, Inc. Common Stock(ANTH) stock opened at —, reached a high of —, and a low of —.
The Anthera Pharmaceuticals, Inc. Common Stock(ANTH)'s current trading volume is 3.5K, compared to an average daily volume of 12.94K.
In the last year, Anthera Pharmaceuticals, Inc. Common Stock(ANTH) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, Anthera Pharmaceuticals, Inc. Common Stock(ANTH) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.